MedDataX Logo

Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects

NCT ID: NCT00315965

Last Updated: 2007-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

107 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using a rapidly responding nitric oxide analyzer in a new developed modular lung-function-setup we are going to measure steady-state NO diffusing capacity in 107 healthy subjects (age 6-45 years). The results will be compared to those measured by using carbon monoxide single-breath estimates. We like to show that the new method is sufficient to measure exactly lung diffusion capacity in this collective.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Diffusing Capacity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nitric oxide, Carbon monoxide, Helium

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers
* Lung function testing possible
* Written consent

Exclusion Criteria

* Pulmonary, neuromuscular, cardiovascular, endocrinological illness
* Pregnancy
* Abuse of nicotine, alcohol, drugs during the last two years
Minimum Eligible Age

6 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Tuebingen

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tobias Pantalitschka, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tuebingen, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University children´s hospital

Tübingen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tobias Pantalitschka, MD

Role: CONTACT

[email protected]
+49 70712984711

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tobias Pantalitschka, MD

Role: primary

[email protected]
+49 7071 2984711

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESNOD-01

Identifier Type: -

Identifier Source: org_study_id